TTY Biopharm Company Company Description

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.

The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments.

It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments.

The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu.

In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism.

Further, the company engages in the selling functional foods; and import and export trading and investment activities.

The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.

TTY Biopharm Company Limited

Country	Taiwan
Founded	1960
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	342

Contact Details

Address: No.3-1, Park Street Taipei, 11503 Taiwan
Phone	886 2 2652 5999
Website	tty.com.tw

Stock Details

Ticker Symbol	4105
Exchange	Taipei Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0004105002
SIC Code	2834

Key Executives

Name	Position
Kuo-Chiang Chang	Chief Financial Officer
Shu-Wen Wang	Accounting Officer
Shu-Fen Huang	Chief Legal and Compliance Officer
Wei-Ying Yin	Director of Public Affairs Department
Jen-Yang Chang	Chief Human Resource Officer
Si-Yuan Yang	Senior Vice President
Allen Chu	Head of Intensive Care Business Unit
Ching-Lan Hou	General Manager
Yung-Min Chiang	Chief Auditor